Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cancer clinics study how to spot Patients' hidden struggles

NCT ID NCT06412029

Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 2 times

Summary

This study looks at how community cancer clinics screen for health-related social needs, like help with housing, food, or transportation. Researchers will work with 144 clinic staff to understand what helps or hinders screening. The goal is to create custom plans to make screening more effective, so patients get the support they need.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help cancer clinics better identify and address patients' social needs, potentially improving overall care.
What could go wrong
This is an observational study, not testing a treatment. It may not lead to direct changes in patient health or outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 144 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

NCI Community Oncology Research Program (NCORP) clinics

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Part 1 NCORP PRACTICES: * Must be an affiliate or sub-affiliate of an NCORP Community or Minority Underserved Community site * Must provide outpatient oncology care * Must be a NCORP practice (defined as one or more NCORP affiliates/sub-affiliates, that have a common administrative structure and share providers and/or patients) * Must have identified two or more Practice Staff that are available and willing to participate on the Practice Interest Form * Must have identified at least 1-3 outpatient oncology clinics willing to participate on the Practice Interest Form CLINICS: * 1-3 clinics within the practice should be selected * Clinics may or may not be located in different physical locations * The investigators will encourage NCORP practices to select clinics within a practice that differ in current or potential implementation of health related social needs (HRSN) screening (e.g., different clinic workflow or staff, different screening triggers, different tools), so that heterogeneity within NCORP practices can be captured * Clinics must be willing to allow Practice Staff participants to observe the clinical operations in-person PRACTICE STAFF: * Must be willing and able to take time to observe in person and document 1-3 selected clinics within the practice (approximately 2-3 hours per clinic) * Must be staff at the selected and enrolled practice. Suggestions of appropriate staff are cancer care delivery research (CCDR) Lead, research nurse, clinical research coordinator or NCORP Administrators. Staff members with primary clinical roles may also be appropriate, if available * Must be willing and able to participate in two 1.5 hour virtual training sessions * Must be willing to interview Clinic Key Informants (approximately 30 minutes per interview; in-person or remotely over the internet or by phone) * If the clinic is chosen for Part 2, must be willing to schedule an interview between Clinic Key Informant and Wake Forest health HRSN Study Team or designee * If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend * Must be willing to be recorded when participating in interviews and the workshop. CLINIC KEY INFORMANT: * Must be willing to participate in Part 1 Operational Assessment, which involves a semi-structured interview (approximately 30 minutes; in-person or remotely over the internet or by phone) and a brief Non-patient Demographics Survey (approximately 5 minutes) * If the clinic is chosen for Part 2, must be willing to participate in an additional 45 minute interview (remotely over the internet or by phone) * If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend Part 3 STAFF WORKSHOP PARTICIPANT: * Must be a clinic stakeholder (e.g., providers, practice managers, etc.) of the selected clinic * Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend * Must be willing to be recorded when participating in interviews and the workshop. PATIENT WORKSHOP PARTICIPANT: * Must be a prospective clinic stakeholder (e.g., patient representative) of the selected clinic * Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend * Must have received cancer treatment at the selected clinic within the last five years * Must be willing to be recorded when participating in the workshop. Exclusion Criteria: Part 1 PRACTICE STAFF: \*\* Unable to understand, read and communicate in English, as the trainings and observations will be documented in English Part 3 STAFF WORKSHOP PARTICIPANT: \*\* Unable to understand, read and communicate in English, as the workshop will be conducted in English PATIENT WORKSHOP PARTICIPANT: \*\* Unable to understand, read and communicate in English, as the workshop will be conducted in English

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    37 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aurora Cancer Care-Grafton

    Grafton, Wisconsin, 53024, United States

  • Aurora Cancer Care-Kenosha South

    Kenosha, Wisconsin, 53142, United States

  • Aurora Saint Luke's Medical Center

    Milwaukee, Wisconsin, 53215, United States

  • Cancer Hematology Centers - Flint

    Flint, Michigan, 48503, United States

  • Carle Cancer Center

    Urbana, Illinois, 61801, United States

  • Carle Cancer Institute Normal

    Normal, Illinois, 61761, United States

  • Carle Physician Group-Effingham

    Effingham, Illinois, 62401, United States

  • Carle Physician Group-Mattoon/Charleston

    Mattoon, Illinois, 61938, United States

  • Carle at The Riverfront

    Danville, Illinois, 61832, United States

  • Central Care Cancer Center - Bolivar

    Bolivar, Missouri, 65613, United States

  • Centro Comprensivo de Cancer de UPR

    San Juan, 00927, Puerto Rico

  • Christiana Care - Union Hospital

    Elkton, Maryland, 21921, United States

  • CoxHealth South Hospital

    Springfield, Missouri, 65807, United States

  • Essentia Health Cancer Center

    Duluth, Minnesota, 55415, United States

  • Essentia Health Cancer Center-South University Clinic

    Fargo, North Dakota, 58103, United States

  • Essentia Health Saint Joseph's Medical Center

    Brainerd, Minnesota, 56401, United States

  • FHP Health Center-Guam

    Tamuning, GU, 96913, Guam

  • FirstHealth of the Carolinas-Moore Regional Hospital

    Pinehurst, North Carolina, 28374, United States

  • Geisinger Medical Center

    Danville, Pennsylvania, 17822, United States

  • Genesee Hematology Oncology PC

    Flint, Michigan, 48503, United States

  • Genesys Hurley Cancer Institute

    Flint, Michigan, 48503, United States

  • Helen F Graham Cancer Center

    Newark, Delaware, 19713, United States

  • Hennepin County Medical Center

    Minneapolis, Minnesota, 55415, United States

  • Illinois CancerCare-Peoria

    Peoria, Illinois, 61615, United States

  • Iowa Methodist Medical Center

    Des Moines, Iowa, 50309, United States

  • MaineHealth Cancer Care - Brunswick

    Brunswick, Maine, 04011, United States

  • Mission Cancer and Blood - Ankeny

    Ankeny, Iowa, 50023, United States

  • Mission Cancer and Blood - Des Moines

    Des Moines, Iowa, 50309, United States

  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

    New York, New York, 10032, United States

  • Penobscot Bay Medical Center

    Rockport, Maine, 04856, United States

  • Prisma Health Cancer Institute - Butternut

    Greenville, South Carolina, 29605, United States

  • Prisma Health Cancer Institute - Faris

    Greenville, South Carolina, 29605, United States

  • Puerto Rico Hematology Oncology Group

    Bayamón, 00961, Puerto Rico

  • San Juan City Hospital

    San Juan, 00936, Puerto Rico

  • ThedaCare Regional Cancer Center

    Appleton, Wisconsin, 54911, United States

  • University Medical Center New Orleans

    New Orleans, Louisiana, 70112, United States

  • Wake Forest NCORP Research Base

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.